Craig L. Martin
Analyst · Barclays
Thank you, John, and good morning, everyone. We'll start on Slide 8, growth strategy. You've seen this slide largely before. I'm going to talk about the first 4 bullets in a little more detail later on. Our business relationship model continues to be a differentiator. We have good market diversity and I'll talk about how we're leveraging that. We have a good geographic presence as well. We've got a good solid cash position, both for acquisitions and to pay down our debt. And the bullet I won't talk more about after this slide is the last one, continue to drive down costs. The market remains price sensitive. We still are not seeing that point in the marketplace where price is not an issue and where we're starting to see margin expansion other than in a most minor way. So it's really important that we drive down our costs. In addition, we do see substantial synergies from SKM, and we think we want to act more quickly to obtain those synergies. So we're pushing hard to get those quicker and in greater magnitude as we look forward. We're also putting an intense focus on our operational efficiency. John has talked about the restructuring. That will also give us the opportunity to correct a couple of project performance issues that led to some of the problems that we talked about earlier. Moving on now to Slide 9. This is our relationship-based business model. You can see that it's pretty much what we've always described, what I think of as a virtuous circle of customer relationship development, good outcomes for the customer, which leads to more business with that customer. I'm pleased that again this quarter, our repeat business was over 96%. So we've had another strong quarter in terms of customer development, customer relationships and repurchase loyalty. Moving on now to Slide 10. You can see how the business breaks out by markets. This is pretty much the same as last quarter, so there's not a lot of movement in any of these numbers. And I'll talk about each one of these in more detail in the upcoming slides. So let's turn now to Slide 11, that's the slide titled Public and Institutional. Let me walk through these markets and give you a sense of what's going on. In the national governments market, things are definitely improving. The budget is providing some funding certainty, we're starting to see a lot of projects get released. There's money out there that's unspent at this point in the U.S. federal budget, and our customers are pushing hard to get it spent before the end of September. And that's a real positive for us. Major expansions in the Asia-Pacific area for U.S. military. It's one of the places where the synergies that we got with SKM are going to be a big benefit to us in terms of our ability to attack those markets and grow our business in Asia Pacific for the federal government. And on the U.K. side, U.K. defense remains very buoyant, and there are a number of major opportunities, probably more opportunities than we can chase to support the U.K. defense department at a very high level. Now we continue to see good business in the U.K. in nuclear cleanup. Recall that we acquired Stobbarts recently, a construction capability, added to our cleanup capability in the Sellafield area. There's $4 billion to be spent there on projects that we think Jacobs is in an excellent position to win. And we're starting to see another batch of spending in environmental remediation in the U.S. And so we think there's going to be some decent opportunities in that area as well. And then finally, we finally managed to penetrate the intelligence community through an acquisition. It's been a very difficult thing to break into the intelligence community, but we're now in a very outstanding position. And I think we'll see significant growth from the support of the intelligence committee based on our strong skills in that area. Moving on now to infrastructure. We've described that market as strong, it certainly is. You can see our comment on road, rail, airport opportunities are abundant, and particularly the U.S. and U.K. markets are very strong right now. So there's a lot of good activity there. We're seeing lots of activity in water projects globally, particularly in Asia Pacific and the Middle East. This is a strength that we got with the SKM acquisition. Jacobs had a small capability in water and wastewater prior to the acquisition. We're now one of the dominant players in the industry globally. So we think we're going to see a nice opportunity to continue to grow the business in water projects and we already made a couple of small announcements in that area since the SKM acquisition. In telecom, we see a lot of investment coming. There's just an enormous amount of activity there, and we're on track to see that become a $1 billion business for Jacobs. So I'm very excited about telecom, it's one of the areas we're going to continue to consider strategic niche investments. And then gas distribution, the whole pipeline safety area is another growth opportunity for us. We're doing a review of our prospects in that business already. We've already won 2 of the bigger programs. But there are many, many more programs of substantial size to be won, and it's going to play very well to Jacobs' strength in that regard. Moving on to the buildings business. This is a business for us, I remind you of every quarter, that's driven by business -- buildings with technical content. So for us, it's buildings where what's on the inside is more important on what's on the outside. High-tech's a big business, I'll talk about that more in a minute. Aviation, scientific, education, in particular secondary and tertiary education, health care, hospitals. In general, lots of activity for us in this area and areas where we have real strength. The fact that we are in a tech building differentiator for us is a positive across almost all the markets, and we think about things like the data centers, mission-critical facilities, that's a tremendous strength of Jacobs, probably the leader in the industry there. And we expect $30 billion of growth in that industry between now and the end of 2020. Again, the last 2 categories, both buildings and infrastructure, we've had tremendous impact from the SKM acquisition because it's been a significant add to our capability. We're doing a really good job of positioning and getting joint wins in that part of the business. The other good news to point here is the backlog growth. If you look at the backlog numbers, we have both good quarter-over-quarter and year-over-year growth in backlog. I think that sort of goes against the general belief that these are weak markets. Whether they are or aren't globally, we're clearly in a position where we're growing our share and taking position in the public and institutional marketplace. Turning now to Slide 12. This is the industrial area that we talk about, kind of a mix of the stuff that doesn't conveniently fit anywhere else. Now let me start with pharmabio. That market is improving for us. The project pipeline still a little mixed, but it is driving capital investments. And we had a couple of announcements last quarter that I think are worth pointing out. We won, again, Facility of the Year for Novartis in 2013. I think that's our sixth or seventh Facility of the Year win in the pharmabio business. We were also awarded a developing countries modular program with Pfizer that I think will be -- turn out to be a very strong program over time. And probably more noteworthy than the press release would suggest on the surface. Our clients are investing a lot in India and Asia. You can see, we see significant growth in the India market. And frankly, our know-how, our ability to deliver things, like the Facility of the Year, and our geographic reach are key to win work with these customers, and we're very well positioned across the globe to continue to grow with the pharmabio customer. And then given our dominant position, our ability to do modular and that sort of thing, there's been some good news. Some of the mergers and acquisitions activity in the pharma industry looks like it's going to be a very strong plus for us. So we see there some significant opportunities that are going to be created by some of these recent merger acquisitions that should leverage up into a number of projects for Jacobs in the pharma space. Moving on to mining and minerals. Again, we say it's growing and that contravenes conventional wisdom. But for us, it continues to be a share game, and we believe we're continuing to grow our share in the marketplace. SKM's capabilities are very complementary to ours. And so we're seeing ourselves as better able to compete for projects around the globe. And the good news is on the big project side, there are now a few big projects in the proposal phase. Still in the study and FEED stage of those proposals but the prospects for major opportunities are better than they've been in the last few quarters. On the sustaining capital market, we've done very well. We talked already about the Calama win last quarter. But we're now seeing pretty substantial sustaining capital opportunities in the $500 million plus sort of scale. And we believe that's a real strength of Jacobs and that we'll be in a wonderful position to take advantage of those opportunities and should be able to win more than our share. As we've said all along, that sustaining capital part of the business has been an under-exploited part of the mining and minerals sector, and we intend to continue to take advantage of that in our growth. And then as I mentioned earlier, we do have a very clear full-spectrum service capability today that's moving us to be the dominant player in the mining, minerals industry in both Australia and in South America. Moving on now to the all other category, power, pulp and paper, high-tech, food and consumer products. It's kind of a mixed bag. There's good news and bad news in those markets, depending on which ones you look at. Some of the better markets right now, the food and consumer products, fast-moving consumer goods, FMCG they call it, is pretty strong for us. Those markets are becoming very India-centric. By that I mean that the customers want to center their development and their leadership of their programs in India and then leverage the rest of the world. Our position in India is relatively unique in that we're a full-service company in India, which positions us very well to take advantage of these international alliances that want an India-centric focus. A lot of money in CapEx in terms of industrial facility upgrades. We'll take advantage of that. And we are doing well in our limited position in the power market. A nice announcement for the EDF nuclear new build market last quarter puts us in a wonderful position to take advantage of nuclear new build in the U.K. We're seeing increasing demands for power work in the Middle East. And the SKM team brought us a very strong niche in the geothermal industry. So another positive for us. Overall, the backlog is flat quarter-over-quarter. And I think given the general perception of those markets, that shows we are doing a good job in sustaining our business there in spite of weak markets. Moving on now to Slide 13. This is the process part of our business. You can see backlog is up 16% year-over-year, I think that's a very good story. Starting with refining, there's a new area of focus on these reliability and safety projects. This comes under the general heading of ISA 84. It looks like the capital spend there will be $20 billion between -- over the next 5 to 7 years. It is largely a controls issue, which plays to one of our strengths, and it's very intense pro-services activity relative to big construction EPC projects. So we think that's going to be a real boost for our refining business as we go forward. Lots of CapEx being spent in the U.S., Middle East and Asia. The usual things that you hear about. Crude slate changes continue to be a factor as people swing from light sweet liquids to heavy sour crudes. A lot of general activity in terms of just creep [ph] upgrades in terms of refinery capacity. So it's generally been a good business, looks like it's going to stay a good business. There's also lots of potential activity in bigger programs in Asia and South America and certainly, in Brazil where they're predicting a huge investment. Our position there with our acquisition of Guimar puts us in an excellent spot. We've talked before about Tier 3 gasoline opportunities. Most of those have not yet been awarded, something like 60% of those opportunities are yet to go. Of the awards that have been made, we've won over 50% of the Tier 3 opportunity. So as we predicted, that's going to be a good business for us. Most of those are still in conceptual and FEED stage, so there's a lot of prospective opportunity. Oil and gas, it's a strong market globally, we talk about it a lot. I think the good news there is we had 2 very significant wins in the quarter that we've been able to announce. BP's Khazzan program, of which the first phase is $2 billion in Oman and the expected investment is $16 billion. Jacobs has won the contract there to support BP. And then here in the U.S., we won ConocoPhillips' Lower 48 program to support them in their onshore investments. Both of those are pretty significant, I think, in terms of our ability to continue to grow the oil and gas business for Jacobs. In the oil sands, we're seeing lots of focus on innovation and capital efficiencies. And we really have a strong offering there, both in terms of our gen-10 separate processing facility and modular delivery of the well pads. There's every reason to think that we're going to be able to continue to be the dominant player in the oil sands and continue to grow our business. Now everybody knows about gas monetization, there's a lot of activity there. The good news there is that there's some increasing opportunity for us. We're still not going to be a major player in the LNG game, but we are seeing opportunities to support LNG projects, opportunities to support the customer on the owners' engineering side and opportunities to do sort of balance the plant, offsite utilities, supply to the LNG facility itself. And then we see a lot of opportunity in pipeline services. We've made a significant acquisition there, as I think you know from last quarter, there's a ton of money going to be spent and we expect that, that will be an area where we'll be able to capitalize on it pretty significantly. And then chemicals is very strong. If you think back, at one time, this was 12% or 13% of revenues, today, it's 22%. The U.S. expansion in chemicals is enormous and a lot of that's driven obviously by the low-cost gas that's coming off the conventional-unconventional gas exploration and development. But the good news about that is in addition to ethylene, which is the big driver, there's a significant amount of derivatives business, and that's an area that plays very strongly to Jacobs' capability. And we continue to believe we're going to be able to be successful in executing a number of sizable derivatives projects based on this ethylene expansion. We got tons of projects in pre-FEED and FEED and lots of projects out there in front of us. The methanol business also looks to continue to be a strong business for us. And we're finally starting to see a very few jobs being released to execute or that we are being told to be released to execute in the next couple of quarters. That's a real positive for us because it means -- indicates that a big part of these jobs are moving forward and that's where the big impact on the P&L will come. So overall, the process business looks like a positive for us as we look forward. Turning now to Slide 14. We continue to have a strong acquisition pipeline. We are going to be very niche focused for a while, mostly concentrating on North America and on the upstream and telecommunications business, where we think there's a lot of leverage. The acquisitions that we have made recently, the Eagleton acquisition and the pipeline business, they were very synergistic day 1, terrific acquisition. We've been able to take a significant share of opportunities into the company that would not have otherwise been opportunities we could chase as part of expansions that supply to a number of our refinery companies, as well as some major compression and pipeline projects planned for Canada and the U.S. We also have announced the FNS acquisition, that's the intelligence-community related acquisition that I mentioned earlier, really important to us to be in that club. If we are successful, as I believe we will be with that acquisition, we'll be able to expand our presence in the intelligence community very significantly and we're really excited about the leverage that, that acquisition represents. As I said, our focus going forward is pretty niche oriented. We don't really have any major acquisitions in the plan for the foreseeable future. It's not to say something won't come along, but that's where we are at the moment. Turning now to Slide 15. We've had a history of solid growth. And we've got a good, strong relationship-based business model with 96% repeat business. We've got diversified markets, geographies and services, and fuels growth and limits exposure. It works for us. If you look at the public sector backlog growth, I think it's a clear indication of how we're able to leverage our diversification. We've got a good solid balance sheet to expand our business, both organically and through the right kinds of acquisitions. And when the times are such we don't need all that cash, we've got a debt reduction program that's working well for us as well. John mentioned that earlier. Our cost position continues to create a competitive advantage for us, and the restructuring and integration actions that we're talking about really are going to fuel 2015 growth. So I'm pretty excited about it. If I were to summarize, we certainly had a disappointing first half. That's behind us now and we are taking aggressive action to deal with that and position for the future, both through the restructuring, which will address and improve our cost posture and address the project performance issues, as well as driving SKM. SKM's -- the synergies are well above what our expectations were when we put this deal together, both cost synergies, in our opportunity to obtain savings, and market synergies, in terms of leveraging new business. So we're accelerating our actions to get those benefits even more quickly. When you couple the things we're doing in terms of taking action with 11 straight quarters of greater than 110% book-to-bill and record backlog, I think we have a very solid outlook going forward. I'm not happy with our first half, but I'm pleased with where we are as a business. And with that, Betty, we'll open it up to questions.